Table 1.
Demographic and clinical characteristics of participants.
| Characteristic | Probiotic group (n = 35) | Placebo group (n = 35) | P -value |
|---|---|---|---|
| Mean age (±SD, years) | 60.5 (7.0) | 60.2 (5.8) | 0.869 |
| Female sex, n (%) | 17 (48.6%) | 18 (51.4%) | 0.811 |
| Education (±SD, years) | 9.3 (2.6) | 9.1 (2.8) | 0.696 |
| BMI (±SD, kg/m2) | 24.9 (1.7) | 24.6 (1.5) | 0.328 |
| Epileptic history (±SD, years) | 10.5 (5.1) | 9.7 (4.9) | 0.465 |
| Seizure frequency (±SD, seizures/month) | 5.4 (1.4) | 5.6 (1.5) | 0.568 |
| Focus location, n (%) | 0.632 | ||
| Left | 16 (45.7%) | 18 (51.4%) | |
| Right | 19 (54.3%) | 17 (48.6%) | |
| Number of AEDs, n (%) | 0.874 | ||
| 1 | 9 (25.7 %) | 10 (28.6 %) | |
| 2 | 14 (40 %) | 15 (42.9 %) | |
| 3+ | 12 (34.3 %) | 10 (28.5 %) |
Continuous variables were analyzed by Student's t-tests, and categorical variables were assessed by chi-square test. No significant differences between groups.